Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health
Ferring Pharmaceuticals and BioInnovation Institute announce a new strategic collaboration to accelerate innovation in women’s health.
BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals A/S (Ferring) have expanded their collaboration with the objective to accelerate world-class life science innovation within women’s health. New activities will include supporting BII to source and potentially fund and incubate early-stage start-ups and projects within the field of reproductive medicine.